Comparisons of sixth and seventh edition of the american joint cancer committee staging systems for esophageal cancer

Annals of Surgical Oncology

Volumn 21, Issue 2, 2014, Pages 583-588

  Yam, Po Chu ^a   Tong, Daniel ^b   Law, Simon ^b  

^a KWONG WAH HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; ESOPHAGUS CANCER; FEMALE; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84896727474     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3335-5     Document Type: Article

References (24)

1. Lin CS, Chang SC, Wei YH, Chou TY, Wu YC, Lin HC, et al. Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2009;87:1056-65.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
3. Howlader N NA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK, editors. SEER Cancer Statistics Review. 1975-2008. Accessed September 15, 2011.
4. Greene FL, Page DL, et al. Esophagus. In: Greene FL, Page DL, FIeming ID, Fritz A, Balch CM, Haller DG, et al., editors. American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 6th edn. New York: Springer; 2002.
5. Rice TW, Blackstone EH, Rybicki LA, Adelstein DJ, Murthy SC, DeCamp MM, et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg. 2003;125:1103-13.
6. Tong DK, Kwong DL, Law S, Wong KH, Wong J. Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease. J Gastrointest Surg. 2008;12:1638-45.
7. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 7th ed. Chicago: Springer 2010.
8. Rice TW, Rusch VW, Ishwaran H, Blackstone EH. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer, Cancer Staging Manuals. Cancer. 2010;116:3763-73.
9. Tong DK, Law S. Management of oesophageal cancer. Indian J Surg. 2009;71:317-25.
10. Law S, Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus. 2001;14:98-103.
11. Tabira Y, Okuma T, Sakaguchi T, Kuhara H, Teshima K, Kawasuji M. Three-field dissection or two-field dissection?-A proposal of new algorithm for lymphadenectomy. Hepatogastroenterology. 2004;51:1015-20.
12. Rusch VW. Should the esophageal cancer staging system be revised? J Thorac Cardiovasc Surg. 2003;125:992-3.
13. Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2006;132:1374-81.
14. Igaki H, Kato H, Tachimori Y, Nakanishi Y. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery. 2003;133:368-74.
15. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245:717-25.
16. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-3.
17. Korst RJ, Rusch VW, Venkatraman E, Bains MS, Burt ME, Downey RJ, et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg. 1998;115:660-9; discussion 669-70.
18. Hsu PK, Wu YC, Chou TY, Huang CS, Hsu WH. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg. 2010;89:1024-31.
19. Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, et al. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg. 1994;219:310-6.
20. Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee PC, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221-6.
21. Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, et al. Worldwide esophageal cancer collaboration. Dis Esophagus. 2009;22:1-8.
22. Bogoevski D, Onken F, Koenig A, Kaifi JT, Schurr P, Sauter G, et al. Is it time for a new TNM classification in esophageal carcinoma? Ann Surg. 2008;247:633-41.
23. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer. 2002;95:1434-43.
24. Doki Y, Ishikawa O, Takachi K, Miyashiro I, Sasaki Y, Ohigashi H, et al. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg. 2005;29:700-7.